Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Policy
The Supreme People’s Court of China has ruled against two Chinese companies accused of infringing Novozymes’ patent on a glucoamylase enzyme used to make fuel and beverage ethanol. Shandong Longda Bio-Products and Jiangsu Boli Bioproducts had initially been found in violation of the Novozymes patent by a lower court in 2011, but the companies appealed, arguing against the patent’s validity. Novozymes says the legal win will encourage further development of the Chinese biotechnology industry.
This article has been sent to the following recipient: